Early Detection Research Network

Shah, Chirayu

Contact Information

Email: mailto:chirayu.shah@vanderbilt.edu
Fax: 615-343-1578
Co-Investigator
3565
None given

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

None Available.

Closed Protocols

No closed protocols.

Publications

Publication Name PubMed ID Journal
A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy. 28387221 Sci Rep
A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. 24132637 Sci Transl Med
Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis. 25247519 JAMA
Advanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancer. 23708067 Cancer J
Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer. 27615397 J Thorac Oncol
Biomarkers of risk to develop lung cancer in the new screening era. 27195276 Ann Transl Med
Biomarkers to the rescue in a lung nodule epidemic. 24516023 J. Clin. Oncol.
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. 25073001 Am. J. Respir. Crit. Care Med.
Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial. 27509046 PLoS ONE
Early detection of NSCLC with scFv selected against IgM autoantibody. 23585862 PLoS ONE
Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma. 28731711 J. Proteome Res.
Indeterminate pulmonary nodules: risk for having or for developing lung cancer? 25348855 Cancer Prev Res (Phila)
Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. 27554763 Cancer Prev Res (Phila)
Integrated digital error suppression for improved detection of circulating tumor DNA. 27018799 Nat. Biotechnol.
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. 23940286 J. Natl. Cancer Inst.
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. 26801409 BMC Pulm Med
Lung cancer screening and smoking cessation: a teachable moment? 24872542 J. Natl. Cancer Inst.
Predicting lung cancer prior to surgical resection in patients with lung nodules. 25170644 J Thorac Oncol
Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules. 27663588 Clin. Cancer Res.
Reproducibility of Volumetric Computed Tomography of Stable Small Pulmonary Nodules with Implications on Estimated Growth Rate and Optimal Scan Interval. 26379272 PLoS ONE
Secretory IgA from submucosal glands does not compensate for its airway surface deficiency in chronic obstructive pulmonary disease. 26432569 Virchows Arch.
Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization. 25035215 Int. J. Radiat. Oncol. Biol. Phys.
The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. 27882349 JCI Insight
The Pursuit of Noninvasive Diagnosis of Lung Cancer. 27732989 Semin Respir Crit Care Med
The state of molecular biomarkers for the early detection of lung cancer. 22689914 Cancer Prev Res (Phila)
Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometry. 24954171 Anal. Chem.
Validation of a multiprotein plasma classifier to identify benign lung nodules. 25590604 J Thorac Oncol

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.